APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR Gamma

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nuclear Receptor ROR Gamma Industry Growth and Trends Forecast to 2032

19 December 2025119 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR Gamma Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR Gamma Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR Gamma Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Nuclear Receptor ROR Gamma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Receptor ROR Gamma include Eli Lilly, GlaxoSmithKline Plc, Biogen Inc, Beijing Hanmi Pharmaceutical, Reata Pharmaceuticals Inc, Phenex Pharmaceuticals AG, Pfizer Inc, Lead Pharma Holding BV and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nuclear Receptor ROR Gamma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nuclear Receptor ROR Gamma market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Receptor ROR Gamma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Receptor ROR Gamma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nuclear Receptor ROR Gamma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nuclear Receptor ROR Gamma Market by Company

Eli Lilly

GlaxoSmithKline Plc

Biogen Inc

Beijing Hanmi Pharmaceutical

Reata Pharmaceuticals Inc

Phenex Pharmaceuticals AG

Pfizer Inc

Lead Pharma Holding BV

Glenmark Pharmaceuticals

Genfit SA

Eurofins Advinus

Celgene Corp

Bristol-Myers Squibb Company

Brickell Biotech Inc

Aurigene Discovery Technologies

AbbVie Inc

Nuclear Receptor ROR Gamma Segment by Type

BBI-6000

R&D Progress

INV-17

IMU-366

GSK-2981278

GRC-39815Action

Others

Nuclear Receptor ROR Gamma Segment by Application

Axial Spondyloarthritis

Asthma

Breast Cancer

Chronic Obstructive Pulmonary Disease

Others

Nuclear Receptor ROR Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclear Receptor ROR Gamma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nuclear Receptor ROR Gamma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BBI-6000 Table 2. Major Company of R&D Progress Table 3. Major Company of INV-17 Table 4. Major Company of IMU-366 Table 5. Major Company of GSK-2981278 Table 6. Major Company of GRC-39815Action Table 7. Major Company of Others Table 8. Global Nuclear Receptor ROR Gamma Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 10. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type (2021-2026) Table 11. Global Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 12. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Type (2021-2026) Table 13. Global Nuclear Receptor ROR Gamma Price by Type (2021-2026) & (US$/Unit) Table 14. Global Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 15. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type (2027-2032) Table 16. Global Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (US$ Million) Table 17. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Type (2027-2032) Table 18. Global Nuclear Receptor ROR Gamma Price by Type (2027-2032) & (US$/Unit) Table 19. North America Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 20. North America Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 22. Europe Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 24. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 26. Latin America Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 28. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (US$ Million) Table 29. Nuclear Receptor ROR Gamma Industry Trends Table 30. Nuclear Receptor ROR Gamma Industry Drivers Table 31. Nuclear Receptor ROR Gamma Industry Opportunities and Challenges Table 32. Nuclear Receptor ROR Gamma Industry Restraints Table 33. Global Nuclear Receptor ROR Gamma Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Nuclear Receptor ROR Gamma Revenue Market Share by Company (2021-2026) Table 35. Global Nuclear Receptor ROR Gamma Sales by Company (2021-2026) & (W Units) Table 36. Global Nuclear Receptor ROR Gamma Sales Share by Company (2021-2026) Table 37. Global Nuclear Receptor ROR Gamma Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Nuclear Receptor ROR Gamma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Nuclear Receptor ROR Gamma Major Company Production Sites and Headquarters Table 40. Global Nuclear Receptor ROR Gamma Company, Product Type & Application Table 41. Global Nuclear Receptor ROR Gamma Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Nuclear Receptor ROR Gamma Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026) & (W Units) Table 46. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2021-2026) Table 47. Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026) & (US$ Million) Table 48. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2021-2026) Table 49. Global Nuclear Receptor ROR Gamma Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Nuclear Receptor ROR Gamma Sales by Region (2027-2032) & (W Units) Table 51. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Region (2027-2032) Table 52. Global Nuclear Receptor ROR Gamma Sales by Region (2027-2032) & (US$ Million) Table 53. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Region (2027-2032) Table 54. Global Nuclear Receptor ROR Gamma Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Nuclear Receptor ROR Gamma Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 57. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application (2021-2026) Table 58. Global Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 59. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Application (2021-2026) Table 60. Global Nuclear Receptor ROR Gamma Price by Application (2021-2026) & (US$/Unit) Table 61. Global Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 62. Global Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application (2027-2032) Table 63. Global Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (US$ Million) Table 64. Global Nuclear Receptor ROR Gamma Sales Market Share in Value by Application (2027-2032) Table 65. Global Nuclear Receptor ROR Gamma Price by Application (2027-2032) & (US$/Unit) Table 66. North America Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 67. North America Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 69. Europe Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 71. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 73. Latin America Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 75. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (US$ Million) Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio Table 80. Eli Lilly Recent Development Table 81. GlaxoSmithKline Plc Company Information Table 82. GlaxoSmithKline Plc Business Overview Table 83. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio Table 85. GlaxoSmithKline Plc Recent Development Table 86. Biogen Inc Company Information Table 87. Biogen Inc Business Overview Table 88. Biogen Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio Table 90. Biogen Inc Recent Development Table 91. Beijing Hanmi Pharmaceutical Company Information Table 92. Beijing Hanmi Pharmaceutical Business Overview Table 93. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio Table 95. Beijing Hanmi Pharmaceutical Recent Development Table 96. Reata Pharmaceuticals Inc Company Information Table 97. Reata Pharmaceuticals Inc Business Overview Table 98. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio Table 100. Reata Pharmaceuticals Inc Recent Development Table 101. Phenex Pharmaceuticals AG Company Information Table 102. Phenex Pharmaceuticals AG Business Overview Table 103. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio Table 105. Phenex Pharmaceuticals AG Recent Development Table 106. Pfizer Inc Company Information Table 107. Pfizer Inc Business Overview Table 108. Pfizer Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio Table 110. Pfizer Inc Recent Development Table 111. Lead Pharma Holding BV Company Information Table 112. Lead Pharma Holding BV Business Overview Table 113. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio Table 115. Lead Pharma Holding BV Recent Development Table 116. Glenmark Pharmaceuticals Company Information Table 117. Glenmark Pharmaceuticals Business Overview Table 118. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio Table 120. Glenmark Pharmaceuticals Recent Development Table 121. Genfit SA Company Information Table 122. Genfit SA Business Overview Table 123. Genfit SA Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Genfit SA Nuclear Receptor ROR Gamma Product Portfolio Table 125. Genfit SA Recent Development Table 126. Eurofins Advinus Company Information Table 127. Eurofins Advinus Business Overview Table 128. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio Table 130. Eurofins Advinus Recent Development Table 131. Celgene Corp Company Information Table 132. Celgene Corp Business Overview Table 133. Celgene Corp Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio Table 135. Celgene Corp Recent Development Table 136. Bristol-Myers Squibb Company Company Information Table 137. Bristol-Myers Squibb Company Business Overview Table 138. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio Table 140. Bristol-Myers Squibb Company Recent Development Table 141. Brickell Biotech Inc Company Information Table 142. Brickell Biotech Inc Business Overview Table 143. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio Table 145. Brickell Biotech Inc Recent Development Table 146. Aurigene Discovery Technologies Company Information Table 147. Aurigene Discovery Technologies Business Overview Table 148. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio Table 150. Aurigene Discovery Technologies Recent Development Table 151. AbbVie Inc Company Information Table 152. AbbVie Inc Business Overview Table 153. AbbVie Inc Nuclear Receptor ROR Gamma Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio Table 155. AbbVie Inc Recent Development Table 156. North America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. North America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 158. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2026) Table 159. North America Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032) & (W Units) Table 160. North America Nuclear Receptor ROR Gamma Sales Market Share Forecast by Country (2027-2032) Table 161. North America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Nuclear Receptor ROR Gamma Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Nuclear Receptor ROR Gamma Market Share by Country (2021-2026) Table 164. North America Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Nuclear Receptor ROR Gamma Market Share Forecast by Country (2027-2032) Table 166. Europe Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 167. Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 168. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2026) Table 169. Europe Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032) & (W Units) Table 170. Europe Nuclear Receptor ROR Gamma Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Nuclear Receptor ROR Gamma Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Nuclear Receptor ROR Gamma Market Share by Country (2021-2026) Table 174. Europe Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Nuclear Receptor ROR Gamma Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 178. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032) & (W Units) Table 180. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Nuclear Receptor ROR Gamma Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Nuclear Receptor ROR Gamma Market Share by Country (2021-2026) Table 184. Asia-Pacific Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Nuclear Receptor ROR Gamma Market Share Forecast by Country (2027-2032) Table 186. Latin America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 187. Latin America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 188. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2026) Table 189. Latin America Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032) & (W Units) Table 190. Latin America Nuclear Receptor ROR Gamma Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Nuclear Receptor ROR Gamma Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Nuclear Receptor ROR Gamma Market Share by Country (2021-2026) Table 194. Latin America Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Nuclear Receptor ROR Gamma Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 198. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032) & (W Units) Table 200. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Nuclear Receptor ROR Gamma Market Share by Country (2021-2026) Table 204. Middle East and Africa Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Nuclear Receptor ROR Gamma Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Nuclear Receptor ROR Gamma Distributors List Table 209. Nuclear Receptor ROR Gamma Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Nuclear Receptor ROR Gamma Image Figure 2. Global Nuclear Receptor ROR Gamma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Receptor ROR Gamma Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Receptor ROR Gamma Sales (2021-2032) & (W Units) Figure 5. BBI-6000 Image Figure 6. Global BBI-6000 Sales YoY Growth (2021-2032) & (W Units) Figure 7. R&D Progress Image Figure 8. Global R&D Progress Sales YoY Growth (2021-2032) & (W Units) Figure 9. INV-17 Image Figure 10. Global INV-17 Sales YoY Growth (2021-2032) & (W Units) Figure 11. IMU-366 Image Figure 12. Global IMU-366 Sales YoY Growth (2021-2032) & (W Units) Figure 13. GSK-2981278 Image Figure 14. Global GSK-2981278 Sales YoY Growth (2021-2032) & (W Units) Figure 15. GRC-39815Action Image Figure 16. Global GRC-39815Action Sales YoY Growth (2021-2032) & (W Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 19. Global Nuclear Receptor ROR Gamma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Nuclear Receptor ROR Gamma Market Share by Type 2025 VS 2032 Figure 21. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2025 Figure 22. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2025 Figure 23. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2025 Figure 24. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2025 Figure 27. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Nuclear Receptor ROR Gamma Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Axial Spondyloarthritis Image Figure 34. Global Axial Spondyloarthritis Sales YoY Growth (2021-2032) & (W Units) Figure 35. Asthma Image Figure 36. Global Asthma Sales YoY Growth (2021-2032) & (W Units) Figure 37. Breast Cancer Image Figure 38. Global Breast Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 39. Chronic Obstructive Pulmonary Disease Image Figure 40. Global Chronic Obstructive Pulmonary Disease Sales YoY Growth (2021-2032) & (W Units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 43. Global Nuclear Receptor ROR Gamma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Nuclear Receptor ROR Gamma Market Share by Application 2025 VS 2032 Figure 45. North America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2025 Figure 46. North America Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2025 Figure 47. Europe Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2025 Figure 48. Europe Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2025 Figure 51. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share in Value by Application in 2025 Figure 55. North America Nuclear Receptor ROR Gamma Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. North America Nuclear Receptor ROR Gamma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Nuclear Receptor ROR Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nuclear Receptor ROR Gamma Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Europe Nuclear Receptor ROR Gamma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Nuclear Receptor ROR Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Asia-Pacific Nuclear Receptor ROR Gamma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Nuclear Receptor ROR Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Nuclear Receptor ROR Gamma Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Latin America Nuclear Receptor ROR Gamma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Nuclear Receptor ROR Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 72. Middle East and Africa Nuclear Receptor ROR Gamma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Nuclear Receptor ROR Gamma Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Nuclear Receptor ROR Gamma Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Nuclear Receptor ROR Gamma Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • BBI-6000
  • R&D Progress
  • INV-17
  • IMU-366
  • GSK-2981278
  • GRC-39815Action
  • Others
Applications
  • Axial Spondyloarthritis
  • Asthma
  • Breast Cancer
  • Chronic Obstructive Pulmonary Disease
  • Others
Companies covered
  • Eli Lilly
  • GlaxoSmithKline Plc
  • Biogen Inc
  • Beijing Hanmi Pharmaceutical
  • Reata Pharmaceuticals Inc
  • Phenex Pharmaceuticals AG
  • Pfizer Inc
  • Lead Pharma Holding BV
  • Glenmark Pharmaceuticals
  • Genfit SA
  • Eurofins Advinus
  • Celgene Corp
  • Bristol-Myers Squibb Company
  • Brickell Biotech Inc
  • Aurigene Discovery Technologies
  • AbbVie Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nuclear Receptor ROR Gamma Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nuclear Receptor ROR Gamma Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nuclear Receptor ROR Gamma Market by Type
  6. 1.3.1 BBI-6000
  7. 1.3.2 R&D Progress
  8. 1.3.3 INV-17
  9. 1.3.4 IMU-366
  10. 1.3.5 GSK-2981278
  11. 1.3.6 GRC-39815Action
  12. 1.3.7 Others
  13. 1.4 Global Nuclear Receptor ROR Gamma Market Size by Type
  14. 1.4.1 Global Nuclear Receptor ROR Gamma Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Nuclear Receptor ROR Gamma Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Nuclear Receptor ROR Gamma Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Nuclear Receptor ROR Gamma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nuclear Receptor ROR Gamma Industry Trends
  2. 2.2 Nuclear Receptor ROR Gamma Industry Drivers
  3. 2.3 Nuclear Receptor ROR Gamma Industry Opportunities and Challenges
  4. 2.4 Nuclear Receptor ROR Gamma Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nuclear Receptor ROR Gamma Revenue (2021-2026)
  2. 3.2 Global Top Players by Nuclear Receptor ROR Gamma Sales (2021-2026)
  3. 3.3 Global Top Players by Nuclear Receptor ROR Gamma Price (2021-2026)
  4. 3.4 Global Nuclear Receptor ROR Gamma Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclear Receptor ROR Gamma Major Company Production Sites & Headquarters
  6. 3.6 Global Nuclear Receptor ROR Gamma Company, Product Type & Application
  7. 3.7 Global Nuclear Receptor ROR Gamma Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclear Receptor ROR Gamma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclear Receptor ROR Gamma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclear Receptor ROR Gamma Tier 1, Tier 2, and Tier 3
4 Nuclear Receptor ROR Gamma Regional Status and Outlook
  1. 4.1 Global Nuclear Receptor ROR Gamma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nuclear Receptor ROR Gamma Historic Market Size by Region
  3. 4.2.1 Global Nuclear Receptor ROR Gamma Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nuclear Receptor ROR Gamma Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nuclear Receptor ROR Gamma Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Region
  7. 4.3.1 Global Nuclear Receptor ROR Gamma Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nuclear Receptor ROR Gamma Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nuclear Receptor ROR Gamma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nuclear Receptor ROR Gamma by Application
  1. 5.1 Nuclear Receptor ROR Gamma Market by Application
  2. 5.1.1 Axial Spondyloarthritis
  3. 5.1.2 Asthma
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Chronic Obstructive Pulmonary Disease
  6. 5.1.5 Others
  7. 5.2 Global Nuclear Receptor ROR Gamma Market Size by Application
  8. 5.2.1 Global Nuclear Receptor ROR Gamma Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Nuclear Receptor ROR Gamma Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Nuclear Receptor ROR Gamma Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Nuclear Receptor ROR Gamma Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Nuclear Receptor ROR Gamma Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Nuclear Receptor ROR Gamma Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Biogen Inc
  14. 6.3.1 Biogen Inc Company Information
  15. 6.3.2 Biogen Inc Business Overview
  16. 6.3.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
  18. 6.3.5 Biogen Inc Recent Developments
  19. 6.4 Beijing Hanmi Pharmaceutical
  20. 6.4.1 Beijing Hanmi Pharmaceutical Company Information
  21. 6.4.2 Beijing Hanmi Pharmaceutical Business Overview
  22. 6.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
  24. 6.4.5 Beijing Hanmi Pharmaceutical Recent Developments
  25. 6.5 Reata Pharmaceuticals Inc
  26. 6.5.1 Reata Pharmaceuticals Inc Company Information
  27. 6.5.2 Reata Pharmaceuticals Inc Business Overview
  28. 6.5.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
  30. 6.5.5 Reata Pharmaceuticals Inc Recent Developments
  31. 6.6 Phenex Pharmaceuticals AG
  32. 6.6.1 Phenex Pharmaceuticals AG Company Information
  33. 6.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 6.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
  36. 6.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 6.7 Pfizer Inc
  38. 6.7.1 Pfizer Inc Company Information
  39. 6.7.2 Pfizer Inc Business Overview
  40. 6.7.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
  42. 6.7.5 Pfizer Inc Recent Developments
  43. 6.8 Lead Pharma Holding BV
  44. 6.8.1 Lead Pharma Holding BV Company Information
  45. 6.8.2 Lead Pharma Holding BV Business Overview
  46. 6.8.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
  48. 6.8.5 Lead Pharma Holding BV Recent Developments
  49. 6.9 Glenmark Pharmaceuticals
  50. 6.9.1 Glenmark Pharmaceuticals Company Information
  51. 6.9.2 Glenmark Pharmaceuticals Business Overview
  52. 6.9.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
  54. 6.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 6.10 Genfit SA
  56. 6.10.1 Genfit SA Company Information
  57. 6.10.2 Genfit SA Business Overview
  58. 6.10.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
  60. 6.10.5 Genfit SA Recent Developments
  61. 6.11 Eurofins Advinus
  62. 6.11.1 Eurofins Advinus Company Information
  63. 6.11.2 Eurofins Advinus Business Overview
  64. 6.11.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
  66. 6.11.5 Eurofins Advinus Recent Developments
  67. 6.12 Celgene Corp
  68. 6.12.1 Celgene Corp Company Information
  69. 6.12.2 Celgene Corp Business Overview
  70. 6.12.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
  72. 6.12.5 Celgene Corp Recent Developments
  73. 6.13 Bristol-Myers Squibb Company
  74. 6.13.1 Bristol-Myers Squibb Company Company Information
  75. 6.13.2 Bristol-Myers Squibb Company Business Overview
  76. 6.13.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
  78. 6.13.5 Bristol-Myers Squibb Company Recent Developments
  79. 6.14 Brickell Biotech Inc
  80. 6.14.1 Brickell Biotech Inc Company Information
  81. 6.14.2 Brickell Biotech Inc Business Overview
  82. 6.14.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
  84. 6.14.5 Brickell Biotech Inc Recent Developments
  85. 6.15 Aurigene Discovery Technologies
  86. 6.15.1 Aurigene Discovery Technologies Company Information
  87. 6.15.2 Aurigene Discovery Technologies Business Overview
  88. 6.15.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
  90. 6.15.5 Aurigene Discovery Technologies Recent Developments
  91. 6.16 AbbVie Inc
  92. 6.16.1 AbbVie Inc Company Information
  93. 6.16.2 AbbVie Inc Business Overview
  94. 6.16.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
  96. 6.16.5 AbbVie Inc Recent Developments
7 North America by Country
  1. 7.1 North America Nuclear Receptor ROR Gamma Sales by Country
  2. 7.1.1 North America Nuclear Receptor ROR Gamma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nuclear Receptor ROR Gamma Sales by Country (2021-2026)
  4. 7.1.3 North America Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nuclear Receptor ROR Gamma Market Size by Country
  6. 7.2.1 North America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nuclear Receptor ROR Gamma Market Size by Country (2021-2026)
  8. 7.2.3 North America Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nuclear Receptor ROR Gamma Sales by Country
  2. 8.1.1 Europe Nuclear Receptor ROR Gamma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2026)
  4. 8.1.3 Europe Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nuclear Receptor ROR Gamma Market Size by Country
  6. 8.2.1 Europe Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nuclear Receptor ROR Gamma Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nuclear Receptor ROR Gamma Sales by Country
  2. 9.1.1 Asia-Pacific Nuclear Receptor ROR Gamma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nuclear Receptor ROR Gamma Market Size by Country
  6. 9.2.1 Asia-Pacific Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nuclear Receptor ROR Gamma Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nuclear Receptor ROR Gamma Sales by Country
  2. 10.1.1 South America Nuclear Receptor ROR Gamma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nuclear Receptor ROR Gamma Sales by Country (2021-2026)
  4. 10.1.3 South America Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nuclear Receptor ROR Gamma Market Size by Country
  6. 10.2.1 South America Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nuclear Receptor ROR Gamma Market Size by Country (2021-2026)
  8. 10.2.3 South America Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country
  2. 11.1.1 Middle East and Africa Nuclear Receptor ROR Gamma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nuclear Receptor ROR Gamma Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country
  6. 11.2.1 Middle East and Africa Nuclear Receptor ROR Gamma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nuclear Receptor ROR Gamma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nuclear Receptor ROR Gamma Value Chain Analysis
  2. 12.1.1 Nuclear Receptor ROR Gamma Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nuclear Receptor ROR Gamma Production Mode & Process
  7. 12.2 Nuclear Receptor ROR Gamma Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nuclear Receptor ROR Gamma Distributors
  10. 12.2.3 Nuclear Receptor ROR Gamma Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst